The forum organized by EFE highlighted urgent needs for enhanced Diagnosis and treatment accessibility in Latin America to combat lung diseases and improve quality of life.
- During the forum, experts emphasized that timely Diagnosis is crucial for effectively addressing lung diseases that significantly affect the quality of life in Latin America.
- Viola stated that the region faces substantial obstacles in accessing updated treatments, primarily due to delays in the approval of new medications necessary for combating these diseases.
- The discussion also indicated that advancements in oncology and pulmonology are essential, with Denmarks experiences serving as a potential model for improving health outcomes in Latin America.
Por Qué Es Relevante
Access to timely Diagnosis and modern treatments is critical in Latin America as it directly impacts the management of lung diseases, ultimately shaping public health and economic stability in the region.